Hizentra-2g (Human normal immunoglobulin Vials) 2g/10ml

Hizentra-2g (Human normal immunoglobulin) is a sterile, ready-to-use immunoglobulin solution supplied in 2g/10ml vials for subcutaneous infusion. This Switzerland-origin product supports immune system function by providing broad-spectrum antibodies. Store below 25°C to maintain stability.

Strength

2g/10ml

Pack Size

Storage

Below 25°C

Manufacturer / TM Owner

Csl Behring Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Human normal immunoglobulin is used to support immune system function in individuals with primary immunodeficiency. It may also be prescribed for certain autoimmune conditions where immune modulation is required. Patients often ask, 'what is Hizentra-2g used for' to understand its role in therapy.

Side Effects

This immunoglobulin solution provides passive immunity by delivering concentrated antibodies from healthy donors. Users typically experience improved resistance to infections over time. Some may notice mild infusion site reactions during administration.

Precautions & Warnings

Keep vials refrigerated until use and protect from light. Inspect solution for particles or discoloration before administration. Always follow healthcare provider instructions for handling and disposal. Avoid freezing to prevent damage to the product.

Avoid Interactions

Concurrent use with live vaccines may reduce vaccine effectiveness; consult a healthcare provider. Immunoglobulins may interact with certain blood products and medications affecting immune response. Discuss all current medications with your provider before starting therapy.

Frequently Asked Questions

Store below 25°C and protect from light. Do not freeze. Use within the recommended timeframe after opening.

Mild reactions may include infusion site discomfort, headache, or fatigue. Severe reactions are rare but require immediate medical attention.

Consult a healthcare provider before use. Safety during pregnancy should be evaluated on an individual basis.

Use the vial within the timeframe specified by your healthcare provider or as indicated on the label.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.